Security
Organogenesis Holdings Inc. Class A Common Stock · ORGO
ORGONASDAQCommon stockCurrentCIK 1661181Updated Oct 6, 2026
Name history
Avista Healthcare Public Acquisition Corp. · through Dec 10, 2018
ORGO price & chart
Loading TradingView…
NASDAQ:ORGO on TradingView ↗About the company
Organogenesis Holdings Inc. is a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and sale of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.
In the news
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 ↗
Recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
424B5 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security Holders
Items 5.02, 5.07
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 509,827,000Source | 446,296,000Source | 406,446,000Source | 461,128,000Source | 443,163,000Source | 519,992,000Source | 467,394,000Source | 458,481,000Source | 598,730,000Source | 497,886,000Source | 460,025,000Source | 449,359,000Source |
| Property, Plant and Equipment, NetUSD | 78,058,000Source | 89,868,000Source | 101,531,000Source | 75,607,000Source | 89,947,000Source | 104,078,000Source | 75,518,000Source | 114,245,000Source | 103,711,000Source | 89,128,000Source | 116,228,000Source | 102,463,000Source |
| GoodwillUSD | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 9,943,000Source | 13,302,000Source | 3,004,000Source | 10,785,000Source | 14,136,000Source | 3,437,000Source | 11,626,000Source | 14,970,000Source | 9,145,000Source | 12,468,000Source | 15,871,000Source | 20,789,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 63,745,000Source | 94,340,000Source | 46,097,000Source | 73,076,000Source | 89,902,000Source | 91,379,000Source | 109,965,000Source | 88,626,000Source | 93,679,000Source | 135,571,000Source | 103,840,000Source | 102,478,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 168,783,000Source | 101,272,000Source | 100,937,000Source | 120,382,000Source | 105,945,000Source | 116,908,000Source | 103,320,000Source | 96,148,000Source | 217,451,000Source | 109,861,000Source | 81,999,000Source | 89,450,000Source |
| Inventory, NetUSD | 39,583,000Source | 27,036,000Source | 29,280,000Source | 33,042,000Source | 26,883,000Source | 28,425,000Source | 29,338,000Source | 27,694,000Source | 29,627,000Source | 26,219,000Source | 28,253,000Source | 24,783,000Source |
| Assets, CurrentUSD | 299,749,000Source | 238,509,000Source | 200,302,000Source | 260,223,000Source | 234,194,000Source | 268,501,000Source | 268,160,000Source | 227,167,000Source | 362,188,000Source | 285,941,000Source | 225,044,000Source | 222,609,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 22,646,000Source | 15,275,000Source | 19,628,000Source | 27,777,000Source | 10,889,000Source | 28,644,000Source | 17,935,000Source | 13,979,000Source | 18,354,000Source | 13,710,000Source | 10,454,000Source | 5,086,000Source |
| Operating Lease, Right-of-Use AssetUSD | 33,304,000Source | 34,943,000Source | 49,912,000Source | 35,257,000Source | 36,572,000Source | 53,742,000Source | 36,756,000Source | 38,616,000Source | 55,749,000Source | 37,110,000Source | 40,118,000Source | 43,192,000Source |
| Other Assets, NoncurrentUSD | 14,410,000Source | 5,013,000Source | 22,925,000Source | 8,730,000Source | 5,851,000Source | 16,129,000Source | 5,834,000Source | 6,709,000Source | 9,203,000Source | 5,005,000Source | 5,990,000Source | 1,520,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 123,848,000Source | 167,749,000Source | 118,314,000Source | 99,909,000Source | 179,662,000Source | 138,645,000Source | 99,325,000Source | 180,451,000Source | 164,812,000Source | 112,570,000Source | 181,362,000Source | 183,690,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source |
| Retained Earnings (Accumulated Deficit)USD | -46,778,000Source | -47,783,000Source | -152,501,000Source | -68,345,000Source | -60,114,000Source | -56,234,000Source | -58,953,000Source | -43,071,000Source | -3,078,000Source | -40,110,000Source | -40,971,000Source | -45,301,000Source |
| Stockholders' Equity Attributable to ParentUSD | 255,128,000Source | 278,547,000Source | 148,268,000Source | 233,242,000Source | 263,501,000Source | 244,555,000Source | 242,902,000Source | 278,030,000Source | 300,129,000Source | 262,897,000Source | 278,663,000Source | 265,669,000Source |
| Additional Paid in Capital, Common StockUSD | 301,893,000Source | 326,317,000Source | 300,756,000Source | 301,574,000Source | 323,602,000Source | 300,776,000Source | 301,842,000Source | 321,088,000Source | 303,194,000Source | 302,994,000Source | 319,621,000Source | 310,957,000Source |
| Liabilities and EquityUSD | 509,827,000Source | 446,296,000Source | 406,446,000Source | 461,128,000Source | 443,163,000Source | 519,992,000Source | 467,394,000Source | 458,481,000Source | 598,730,000Source | 497,886,000Source | 460,025,000Source | 449,359,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 90,319,000Source | 77,281,000Source | 56,963,000Source | 65,839,000Source | 85,727,000Source | 76,021,000Source | 65,053,000Source | 82,799,000Source | 100,124,000Source | 77,477,000Source | 80,509,000Source | 75,023,000Source |
| Operating Lease, Liability, CurrentUSD | 4,785,000Source | 3,926,000Source | 3,807,000Source | 4,796,000Source | 4,081,000Source | 4,764,000Source | 4,353,000Source | 4,675,000Source | 4,949,000Source | 4,272,000Source | 10,004,000Source | 11,708,000Source |
| Accounts Payable, CurrentUSD | 40,219,000Source | 23,971,000Source | 29,291,000Source | 29,723,000Source | 29,390,000Source | 28,615,000Source | 24,660,000Source | 23,230,000Source | 31,949,000Source | 28,911,000Source | 30,724,000Source | 32,330,000Source |
| Operating Lease, Liability, NoncurrentUSD | 23,507,000Source | 22,785,000Source | 21,079,000Source | 24,565,000Source | 23,483,000Source | 21,787,000Source | 25,625,000Source | 24,383,000Source | 22,470,000Source | 25,198,000Source | 19,780,000Source | 41,314,000Source |
| Other Liabilities, NoncurrentUSD | 2,509,000Source | 1,294,000Source | 3,714,000Source | 3,022,000Source | 1,268,000Source | 1,486,000Source | 897,000Source | 1,242,000Source | 1,193,000Source | 894,000Source | 1,213,000Source | 1,122,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 40,310,000Source | 36,101,000Source | — | 26,348,000Source | 38,016,000Source | — | 31,135,000Source | 39,759,000Source | 49,533,000Source | 39,453,000Source | 30,074,000Source | 26,447,000Source |
| Long-term DebtUSD | — | 62,344,000Source | — | — | 63,750,000Source | — | — | 65,156,000Source | — | — | 66,563,000Source | 71,250,000Source |
| Preferred Stock, Value, Issued | — | — | — | — | — | —Source | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 21,567,000Source | 12,331,000Source | -96,267,000Source | -9,392,000Source | -53,156,000Source | -18,843,000Source | 37,032,000Source | 861,000Source | 4,945,000Source | 15,532,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 4,174,000Source | 3,444,000Source | 15,273,000Source | 13,623,000Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,636,000Source | 3,367,000Source | 13,298,000Source | 10,578,000Source | 8,996,000Source | 6,552,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -104,502,000Source | -5,668,000Source | 115,803,000Source | 31,800,000Source | -5,539,000Source | 8,770,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 8,730,000Source | 8,732,000Source | 17,915,000Source | 6,204,000Source | 8,179,000Source | 9,410,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -2,003,000Source | -2,496,000Source | -528,000Source | -2,372,000Source | -108,000Source | 3,260,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | -15,371,000Source | -1,266,000Source | 9,500,000Source | -10,719,000Source | 2,012,000Source | 1,980,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 21,127,000Source | -19,935,000Source | -10,309,000Source | 14,208,000Source | 30,917,000Source | 24,859,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -3,146,000Source | -3,626,000Source | -14,151,000Source | -10,032,000Source | -24,364,000Source | -33,898,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 3,146,000Source | 3,626,000Source | 14,151,000Source | 10,032,000Source | 24,364,000Source | 33,898,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 3,051,000Source | 1,796,000Source | 1,885,000Source | 1,175,000Source | 332,000Source | 648,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | 25,479,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -20,213,000Source | -2,056,000Source | -17,360,000Source | 27,637,000Source | -5,505,000Source | -2,199,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -2,232,000Source | -25,617,000Source | -41,820,000Source | 31,813,000Source | 1,048,000Source | -11,238,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 64,372,000Source | 94,926,000Source | 46,844,000Source | 73,735,000Source | 92,099,000Source | 110,534,000Source | 94,331,000Source | 136,151,000Source | 104,338,000Source | 103,290,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | — | 4,970,000Source | 5,436,000Source | 2,649,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 5,346,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 842,000Source | 834,000Source | — | — | 5,708,000Source | 842,000Source | 3,323,000Source | 3,403,000Source | 4,918,000Source | 4,883,000Source |
| DepreciationUSD | — | — | 4,029,000Source | 3,570,000Source | — | 3,734,000Source | — | 3,444,000Source | 15,273,000Source | 13,623,000Source | 10,448,000Source | 5,845,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | -19,000Source | -188,000Source | -1,140,000Source | -235,000Source | -4,482,000Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | — | — | — | — | — | 0Source | -559,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | -215,000Source | — | — |
| GoodwillUSD | — | — | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source | 28,772,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | -407,000Source | -6,508,000Source | 45,387,000Source | -2,442,000Source | -15,317,000Source | -6,940,000Source | 9,938,000Source | -3,668,000Source | 5,447,000Source | 4,750,000Source |
| InterestExpenseNonoperatingUSD | — | — | -415,000Source | 471,000Source | -138,000Source | -669,000Source | -380,000Source | -961,000Source | -2,281,000Source | 1,544,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 21,567,000Source | 12,331,000Source | -96,267,000Source | -9,392,000Source | -53,156,000Source | -18,843,000Source | 37,032,000Source | 861,000Source | 4,945,000Source | 15,532,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 14,525,000Source | 12,331,000Source | -99,339,000Source | -12,202,000Source | -56,159,000Source | -21,591,000Source | 20,022,000Source | -937,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 433,000Source | -419,000Source | 112,000Source | 742,000Source | 418,000Source | 963,000Source | 2,276,000Source | -1,524,000Source | -2,133,000Source | -2,022,000Source |
| Operating Costs and ExpensesUSD | — | — | 36,251,000Source | 26,796,000Source | 23,673,000Source | 27,630,000Source | 25,772,000Source | 23,723,000Source | 137,522,000Source | — | — | — |
| Operating ExpensesUSD | — | — | 130,137,000Source | 108,935,000Source | 94,747,000Source | 113,581,000Source | 106,119,000Source | 113,439,000Source | 519,475,000Source | 367,585,000Source | 314,134,000Source | 323,570,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 18,000Source | 52,000Source | -26,000Source | 73,000Source | 38,000Source | 2,000Source | -5,000Source | 20,000Source | 57,000Source | -13,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 25,000Source | 157,000Source | 1,247,000Source | — | 2,070,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 150,864,000Source | 115,177,000Source | 43,755,000Source | 101,005,000Source | 37,228,000Source | 86,693,000Source | 564,169,000Source | 482,043,000Source | 433,140,000Source | 450,893,000Source |
| Cost of Goods and Services Sold | — | — | — | —Source | — | — | — | —Source | — | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 79,743,000Source | 71,795,000Source | 53,965,000Source | 73,810,000Source | 65,186,000Source | 72,509,000Source | 326,236,000Source | 294,513,000Source | 269,754,000Source | 283,808,000Source |
| Operating Income (Loss)USD | — | — | 20,727,000Source | 6,242,000Source | -50,992,000Source | -12,576,000Source | -68,891,000Source | -26,746,000Source | 44,694,000Source | -1,283,000Source | 12,525,000Source | 22,304,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 18,000Source | 52,000Source | -26,000Source | 73,000Source | 38,000Source | 2,000Source | -5,000Source | 20,000Source | 57,000Source | -13,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 21,160,000Source | 5,823,000Source | -50,880,000Source | -11,834,000Source | -68,473,000Source | -25,783,000Source | 46,970,000Source | -2,807,000Source | 10,392,000Source | 20,282,000Source |
| Income Tax Expense (Benefit)USD | — | — | -407,000Source | -6,508,000Source | 45,387,000Source | -2,442,000Source | -15,317,000Source | -6,940,000Source | 9,938,000Source | -3,668,000Source | 5,447,000Source | 4,750,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 21,567,000Source | 12,331,000Source | -96,267,000Source | -9,392,000Source | -53,156,000Source | -18,843,000Source | 37,032,000Source | 861,000Source | 4,945,000Source | 15,532,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.11Source | 0.09Source | -0.77Source | -0.1Source | -0.44Source | -0.17Source | 0.16Source | -0.01Source | 0.04Source | 0.12Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.11Source | 0.09Source | -0.77Source | -0.1Source | -0.44Source | -0.17Source | 0.15Source | -0.01Source | 0.04Source | 0.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 126,881,709Source | 132,575,301Source | 128,674,548Source | 126,853,536Source | 127,797,013Source | 126,295,642Source | 126,738,136Source | 131,673,278Source | 131,231,317Source | 130,070,231Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 130,848,995Source | 133,926,755Source | 128,674,548Source | 126,853,536Source | 127,797,013Source | 126,295,642Source | 130,248,412Source | 131,673,278Source | 132,746,727Source | 132,383,152Source |
| Interest Expense (non-operating)USD | — | — | -415,000Source | 471,000Source | -138,000Source | -669,000Source | -380,000Source | -961,000Source | -2,281,000Source | 1,544,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 842,000Source | 834,000Source | — | — | 5,708,000Source | 842,000Source | 3,323,000Source | 3,403,000Source | 4,918,000Source | 4,883,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 438,000Source | 7,051,000Source | 3,435,000Source | 2,770,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | — | 88,381,000Source | — | — | — | 62,970,000Source | — | 366,302,000Source | 326,659,000Source | 345,874,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 2,190,000Source | 2,009,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 14,525,000Source | 12,331,000Source | -99,339,000Source | -12,202,000Source | -56,159,000Source | -21,591,000Source | 20,022,000Source | -937,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 433,000Source | -419,000Source | 112,000Source | 742,000Source | 418,000Source | 963,000Source | 2,276,000Source | -1,524,000Source | -2,133,000Source | -2,022,000Source |
| Operating Costs and ExpensesUSD | — | — | 36,251,000Source | 26,796,000Source | 23,673,000Source | 27,630,000Source | 25,772,000Source | 23,723,000Source | 137,522,000Source | — | — | — |
| Operating ExpensesUSD | — | — | 130,137,000Source | 108,935,000Source | 94,747,000Source | 113,581,000Source | 106,119,000Source | 113,439,000Source | 519,475,000Source | 367,585,000Source | 314,134,000Source | 323,570,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 2,734,000Source | 0Source | 2,902,000Source | 2,681,000Source | 2,844,000Source | 2,627,000Source | 10,830,000Source | 1,386,000Source | — | — |
| Research and Development ExpenseUSD | — | — | 13,221,000Source | 10,344,000Source | 18,297,000Source | 10,395,000Source | 15,161,000Source | 10,640,000Source | 44,542,000Source | 50,271,000Source | 44,380,000Source | 39,762,000Source |
Filing attachments
orgo-ex99_1.htm · 8-K · 2026-08-06
EX-99.1 2 orgo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results CANTON, Mass., (August 6, 2026) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and sale of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results …
Read attachment ↗orgo-ex99_1.htm · 8-K · 2026-05-07
EX-99.1 2 orgo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results CANTON, Mass., (May 7, 2026) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and sale of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for …
Read attachment ↗